Home › NDC Lookup › RxCUI directory › RxCUI 2591428

100 ML vasopressin (USP) 0.2 UNT/ML Injection — RxCUI 2591428

RxNorm drug concept · Semantic clinical drug
RxCUI 2591428 Semantic clinical drug · SCD ● Current RxNorm concept 8 FDA products 9 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2591428
Official name100 ML vasopressin (USP) 0.2 UNT/ML Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asvasopressin (USP) 20 UNT per 100 ML Injection; vasopressin (USP) 20 UNT in 100 ML Injection; vasopressin (USP) 0.2 UNT/ML per 100 ML Injection
FDA products mapped8
Package NDCs mapped9
Reported Medicaid activity (SDUD)789 prescriptions · 11 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Vasopressin: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Vasopressin is being used to raise dangerously low blood pressure caused by a condition called vasodilatory shock — where blood vessels have relaxed too much and other treatments l...
  • What exactly is vasopressin being used for in my (or my family member's) care?
  • Vasopressin is given as a slow, continuous drip through an IV line — you won't take it by mouth or inject it yourself. The clinical team starts at a low rate and gradually adjusts...
  • How will I (or my family member) receive this medication?
📖 Read our full Vasopressin guide →

🕸️ Concept Web — How 100 ML vasopressin (USP) 0.2 UNT/ML Injection Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 100 ML vasopressin (USP) 0.2 UNT/ML Injection RxCUI 2591428

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Vasopressin (USP) 11149
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Vasostrict 1593734
  3. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Vasopressin (USP) Injection 2103181
    • Vasopressin (USP) Injectable Product 1160506
    • Vasopressin (USP) Injection [Vasostrict] 2103183
    • Vasostrict Injectable Product 1593737
    • Injection 1649574
    • Injectable Product 1151126
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Vasopressin (USP) 0.2 UNT/ML SCDC · 2591427
  • Vasopressin (USP) Injection SCDF · 2103181
  • Vasopressin (USP) Injectable Product SCDG · 1160506

Brand-Name Concepts

📦 FDA Products & Package NDCs

8 products · 9 package NDCs
9 package NDCs map to RxCUI 2591428 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00338-9640-12 12 BAG in 1 CARTON (0338-9640-12) / 100 mL in 1 BAG Vasopressin in 0.9% Sodium Chloride Baxter Healthcare Corporation 2023-09-29
00338-9647-12 12 BAG in 1 CARTON (0338-9647-12) / 100 mL in 1 BAG Vasopressin in 0.9% Sodium Chloride Baxter Healthcare Corporation 2023-09-29
42023-0164-10 10 VIAL in 1 CARTON (42023-164-10) / 1 mL in 1 VIAL (42023-... Vasostrict Par Health USA, LLC 2020-08-17
42023-0164-25 25 VIAL in 1 CARTON (42023-164-25) / 1 mL in 1 VIAL (42023-... Vasostrict Par Health USA, LLC 2014-11-12
42023-0190-01 1 VIAL in 1 CARTON (42023-190-01) / 10 mL in 1 VIAL Vasostrict Par Health USA, LLC 2017-02-27
42023-0219-10 10 VIAL in 1 CARTON (42023-219-10) / 100 mL in 1 VIAL (4202... Vasostrict Par Health USA, LLC 2021-12-15
42023-0237-10 10 VIAL in 1 CARTON (42023-237-10) / 100 mL in 1 VIAL (4202... Vasostrict Par Health USA, LLC 2021-12-15
81298-8552-03 10 VIAL, SINGLE-DOSE in 1 CARTON (81298-8552-3) / 100 mL in... Vasopressin in 0.9% Sodium Chloride Long Grove Pharmaceuticals, LLC 2024-07-12
81298-8554-03 10 VIAL, SINGLE-DOSE in 1 CARTON (81298-8554-3) / 100 mL in... Vasopressin in 0.9% Sodium Chloride Long Grove Pharmaceuticals, LLC 2024-07-12
Observed labelers: Par Health USA, LLC (5) · Baxter Healthcare Corporation (2) · Long Grove Pharmaceuticals, LLC (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
CodeDescriptorMapped packagesSources
J2598 Inj, vasopressin, 1 unit 5 CMS
J2596 Vasopressin (long grove) 1 u 2 CMS
J2601 Inj, vasopressin (baxter) 2 CMS
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.